Literature DB >> 27154026

[Optimization of therapy of autoimmune diseases of the eye : Novel approaches].

U Pleyer1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27154026     DOI： 10.1007/s00347-016-0266-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  5 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

Review 2.  [Treatment of posterior noninfectious uveitis : Current situation and future developments].

Authors:  U Pleyer; D Pohlmann; N Stübiger
Journal:  Ophthalmologe       Date:  2016-05       Impact factor: 1.059

Review 3.  [Immunomodulation and neuroprotection in optic neuritis].

Authors:  F Beisse; R Diem
Journal:  Ophthalmologe       Date:  2016-05       Impact factor: 1.059

Review 4.  [Immunomodulatory therapy of autoimmune diseases : Quo vadis?].

Authors:  B F Hoyer; F Hiepe
Journal:  Ophthalmologe       Date:  2016-05       Impact factor: 1.059

Review 5.  [Uveitis associated with juvenile idiopathic arthritis : Optimization of immunomodulatory therapy].

Authors:  A Heiligenhaus; C Tappeiner; K Walscheid; C Heinz
Journal:  Ophthalmologe       Date:  2016-05       Impact factor: 1.059
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.